Continuous Manufacturing Market is estimated to be worth around USD 2 billion in 2030

Roots Analysis is pleased to announce the publication of its recent study, titled, “Continuous Manufacturing Market (Small Molecules and Biologics), 2020 – 2030.” 

The report features an extensive study of the current market landscape and future opportunities for companies with capabilities in continuous manufacturing (both innovator companies with in-house expertise and contract manufacturers). It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes:

·        A  detailed assessment of the overall landscape of companies with capabilities for continuous manufacturing

·        Elaborate profiles of some of the key contract manufacturers active in the pharmaceutical and biopharmaceutical continuous manufacturing market

·        An analysis of the various partnerships related to continuous manufacturing, which have been established since 2013

·        An analysis of the expansions related to continuous manufacturing, which have been established since 2013

·        An estimate of the global, continuous manufacturing capacity, based on the capacities of various industry stakeholders (as available on their respective company websites).

·        A study of the various grants that have been awarded to research institutes engaged in projects related to continuous manufacturing, between 2014 and 2019

·        An in-depth analysis of the various patents that have been filed / granted related to continuous manufacturing till 2019

·        Initiatives taken by the leading pharmaceutical companies (in terms of revenues), covering both partnered as well as in-house projects.

·        A review of the companies offering modular facilities / modular cleanrooms

·        A case study of the companies offering technologies / equipment

·        A case study on the roadmap for the adoption of continuous manufacturing technique